摘要
1文献来源Xia Y, Wang P, Pu L, et al. Preliminary efficacy and safety of perioperative treatment of camrelizumab combined with apatinib in resectable hepatocellular carcinoma (HCC):A prospective phaseⅡstudy[J]. J Clin Oncol,2021,39(15S):Abstr4082.
作者
金浩生
陈志鸿
石宁
吕玲
JIN Hao-sheng;CHEN Zhi-hong;SHI Ning;LV Ling(Department of General Surgery,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;不详)
出处
《循证医学》
2021年第6期337-340,共4页
The Journal of Evidence-Based Medicine
